Racial and Ethnic Disparities in HIV Testing in People Who Use Drugs Admitted to a Tertiary Care Hospital.

Sami Hamdan, Emma Smyth, Meghan E Murphy, Emily D Grussing, Mingrui Wei, Rubeen Guardado, Alysse Wurcel
Author Information
  1. Sami Hamdan: Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
  2. Emma Smyth: Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
  3. Meghan E Murphy: Tufts University School of Medicine, Boston, Massachusetts, USA.
  4. Emily D Grussing: Tufts University School of Medicine, Boston, Massachusetts, USA.
  5. Mingrui Wei: Tufts University School of Medicine, Boston, Massachusetts, USA.
  6. Rubeen Guardado: Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
  7. Alysse Wurcel: Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA. ORCID

Abstract

Ending the HIV epidemic requires increased testing, diagnosis, and linkage to care. In the past 10 years, rates of HIV have increased among people with substance use disorder (SUD). HIV testing is recommended during hospitalization. Despite rising rates of infections and recommendations, HIV testing remains suboptimal. This study sought to detect differences in HIV testing by race and ethnicity in people who use drugs (PWUD) admitted to Tufts Medical Center (TuftsMC). This study is a retrospective review of hospitalized PWUD admitted from January 1, 2017 to December 31, 2020. PWUD were identified through toxicology results, medication prescribed for SUD, and nursing intake questions. The primary outcome of interest was whether an HIV test was ordered during hospitalization. The indicator of interest was race and ethnicity. Of 13,486 PWUD admitted to TuftsMC, only 10% had an HIV test ordered. Compared with White patients, Black patients [adjusted odds ratio (AOR): 0.69, 95% confidence interval (CI) (0.59-0.83)] and Hispanic patients [AOR: 0.68, 95% CI (0.55-0.84)] had decreased odds of receiving an HIV test. Our report is the first to show racial and ethnic differences in HIV testing ordering for hospitalized PWUD. Without access to harm reduction tools and expanded systems-based testing strategies, the HIV epidemic will continue and disproportionately impact minoritized communities.

Keywords

References

  1. JAMA Netw Open. 2021 Apr 1;4(4):e215226 [PMID: 33835175]
  2. AIDS Care. 2021 Oct;33(10):1243-1254 [PMID: 32933322]
  3. MMWR Morb Mortal Wkly Rep. 2022 Jun 24;71(25):820-824 [PMID: 35737573]
  4. Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350 [PMID: 33965972]
  5. Am J Public Health. 2000 Aug;90(8):1212-5 [PMID: 10936998]
  6. AIDS Educ Prev. 2021 Apr;33(2):143-157 [PMID: 33821677]
  7. AIDS Patient Care STDS. 2019 Jan;33(1):25-31 [PMID: 30328693]
  8. Am J Public Health. 2009 Apr;99 Suppl 1:S137-43 [PMID: 19218186]
  9. J Urban Health. 2022 Apr;99(2):293-304 [PMID: 35028876]
  10. J Gen Intern Med. 2021 Jan;36(1):129-137 [PMID: 32918199]
  11. J Subst Abuse Treat. 2021 May;124:108266 [PMID: 33771274]
  12. Med Care. 2016 Jun;54(6):639-44 [PMID: 26918402]
  13. AIDS Behav. 2022 Jan;26(Suppl 1):125-137 [PMID: 34117966]
  14. AIDS Patient Care STDS. 2020 Mar;34(3):102-110 [PMID: 32202928]
  15. Drug Alcohol Depend. 2022 Sep 1;238:109573 [PMID: 35926301]
  16. J Urban Health. 2014 Feb;91(1):151-61 [PMID: 23749458]
  17. Alcohol Clin Exp Res. 2019 Nov;43(11):2431-2437 [PMID: 31596516]
  18. Subst Abuse Treat Prev Policy. 2013 Oct 01;8:35 [PMID: 24079946]
  19. Int J Drug Policy. 2016 Jun;32:11-6 [PMID: 27198555]
  20. PLoS One. 2022 Jul 1;17(7):e0270861 [PMID: 35776746]
  21. Cult Health Sex. 2014 Jun;16(6):710-22 [PMID: 24784224]
  22. JAMA. 2019 Feb 5;321(5):451-452 [PMID: 30629090]
  23. MMWR Morb Mortal Wkly Rep. 1993 Mar 5;42(8):157-8 [PMID: 8437547]
  24. Lancet HIV. 2022 Apr;9(4):e269-e280 [PMID: 35218732]
  25. Drug Alcohol Depend. 2009 Apr 1;101(1-2):101-6 [PMID: 19117698]
  26. J Gen Intern Med. 2022 Jan;37(1):49-56 [PMID: 33821410]
  27. AIDS Care. 2015;27(2):182-8 [PMID: 25298014]
  28. JAMA. 2019 Mar 5;321(9):844-845 [PMID: 30730529]
  29. AIDS Educ Prev. 2011 Jun;23(3 Suppl):70-83 [PMID: 21689038]
  30. Int J Drug Policy. 2018 Jul;57:104-110 [PMID: 29715589]
  31. AIDS Behav. 2020 Jun;24(6):1876-1892 [PMID: 31834541]
  32. AIDS Behav. 2022 Apr;26(4):1047-1055 [PMID: 34510289]
  33. MMWR Morb Mortal Wkly Rep. 2016 Dec 02;65(47):1336-1342 [PMID: 27906906]
  34. Am J Public Health. 2015 Feb;105(2):e75-82 [PMID: 25521875]
  35. J Acquir Immune Defic Syndr. 2021 Jun 1;87(2):e188-e197 [PMID: 33633033]
  36. AIDS Behav. 2013 Jun;17(5):1632-6 [PMID: 23456577]
  37. PLoS One. 2018 Mar 7;13(3):e0190767 [PMID: 29513659]
  38. AIDS Patient Care STDS. 2020 Dec;34(12):516-522 [PMID: 33296271]
  39. PLoS One. 2020 Jul 28;15(7):e0236247 [PMID: 32722724]
  40. J Am Coll Emerg Physicians Open. 2020 May 26;1(4):487-493 [PMID: 33000075]
  41. J Urban Health. 2013 Jun;90(3):482-99 [PMID: 22815053]
  42. PLoS One. 2021 May 18;16(5):e0251756 [PMID: 34003855]
  43. Am J Public Health. 2017 Aug;107(8):1259-1265 [PMID: 28640673]
  44. AIDS Patient Care STDS. 2021 May;35(5):180-187 [PMID: 33901410]
  45. Eur Psychiatry. 2005 Nov;20(7):484-9 [PMID: 16310679]
  46. AIDS. 2007 Jul 31;21(12):1617-24 [PMID: 17630557]
  47. Am J Public Health. 2018 Nov;108(S4):S277-S283 [PMID: 30383431]
  48. Br J Addict. 1989 Nov;84(11):1353-7 [PMID: 2597811]
  49. Public Health Rep. 2011 Sep-Oct;126(5):643-52 [PMID: 21886324]
  50. Clin Infect Dis. 2007 Dec 15;45 Suppl 4:S248-54 [PMID: 18190295]
  51. Lancet. 2021 Mar 20;397(10279):1139-1150 [PMID: 33617769]
  52. AIDS Behav. 2022 May;26(5):1393-1421 [PMID: 34750695]
  53. AIDS Behav. 2022 Jan;26(1):277-283 [PMID: 34287755]
  54. Clin Infect Dis. 2013 Oct;57(8):1164-71 [PMID: 23797289]
  55. AIDS Behav. 2018 Sep;22(9):2773-2787 [PMID: 29468492]
  56. N Engl J Med. 2015 Dec 3;373(23):2281-7 [PMID: 26624243]
  57. J Infect Dis. 2021 Jun 15;223(12):2113-2123 [PMID: 33084891]
  58. AIDS Care. 2005 Feb;17(2):125-40 [PMID: 15763709]
  59. Am J Emerg Med. 2021 Oct;48:269-272 [PMID: 34015610]
  60. N Engl J Med. 2013 Mar 7;368(10):881-4 [PMID: 23425134]

Grants

  1. UL1 TR002544/NCATS NIH HHS
  2. K08 HS026008/AHRQ HHS

MeSH Term

Humans
Ethnicity
White People
Black or African American
Tertiary Care Centers
HIV Infections
HIV Testing
Hospitalization
Substance-Related Disorders

Word Cloud

Created with Highcharts 10.0.0HIVtestingPWUD0admittedtestpatientsepidemicincreasedratespeopleuseSUDhospitalizationstudydifferencesraceethnicityTuftsMChospitalizedinterestorderedodds95%CI]racialEndingrequiresdiagnosislinkagecarepast10yearsamongsubstancedisorderrecommendedDespiterisinginfectionsrecommendationsremainssuboptimalsoughtdetectdrugsTuftsMedicalCenterretrospectivereviewJanuary12017December312020identifiedtoxicologyresultsmedicationprescribednursingintakequestionsprimaryoutcomewhetherindicator1348610%ComparedWhiteBlack[adjustedratioAOR:69confidenceinterval59-083Hispanic[AOR:6855-084decreasedreceivingreportfirstshowethnicorderingWithoutaccessharmreductiontoolsexpandedsystems-basedstrategieswillcontinuedisproportionatelyimpactminoritizedcommunitiesRacialEthnicDisparitiesTestingPeopleUseDrugsAdmittedTertiaryCareHospitalscreeningdisparities

Similar Articles

Cited By